Skip to content

A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension

A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02888093
Enrollment
44
Registered
2016-09-02
Start date
2016-10-31
Completion date
2018-11-30
Last updated
2019-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystocele, Pelvic Organ Prolapse, Uterine Prolapse

Brief summary

Uterosacral ligament suspension (USLS) is a commonly performed, vaginal surgery for the correction of female pelvic organ prolapse. The original description of this procedure included the use of permanent sutures. However, permanent suture use in this vaginal application can result in some minor complication such as persistent vaginal spotting, vaginal discharge and dyspareunia. Subsequent reports on this procedure have utilized delayed-absorbable sutures in order to avoid these complications. Retrospective studies are conflicting as to whether or not absorbable suture provides as durable an anatomic outcome as permanent suture. There are currently no high-quality, prospective studies that have evaluated outcomes of permanent and absorbable suture for uterosacral ligament suspension. This study will recruit women scheduled to undergo USLS with or without other prolapse or anti-incontinence procedures. Participants will be randomized 1:1 to permanent or absorbable suture. Follow up will occur at 6 weeks and 12 months post-operatively. The primary outcome will be Pelvic Organ Prolapse Quantification Exam (POP-Q) point C as measured at the 12 month follow up visit. Subjects and assessors will be blinded.

Detailed description

Patient demographics, relevant histories, baseline physical exam including POP-Q and PFDI-20 data will be abstracted from the electronic medical record following enrollment. This information will be placed into a secure database. The randomization sequence will be generated by randomize.net, a web-based service that provides comprehensive randomization services for randomized controlled trials. The sequence will be randomized 1:1 with blocks of 4 and stratified by surgeon. Concealment will be completely opaque as group allocation will not be revealed until the subject is enrolled on the web-based service and the surgeon has elected to randomize the patient from an internet connection in the operating room. Subjects and assessors will be blinded to study group. The surgeons will, necessarily, not be blinded. Subjects will only be informed of their assigned group upon request following completion of the entire study. USLS with the assigned suture and any scheduled concomitant prolapse and anti-incontinence procedures will be performed. All procedures will be performed by one of two fellowship-trained, Female Pelvic Medicine and Reconstructive Surgery board-certified surgeons. USLS will be performed as initially described by Shull et al with two important differences in technique. First, 2 sutures will be placed through the intermediate portion of each uterosacral ligament instead of 3. Second, when absorbable suture (polydioxanone) is used, the suture will be placed through the full thickness of the anterior and posterior vaginal walls. Follow up exams will occur at 6 weeks and 12 months post-operatively and will include a POP-Q exam. The 6 week follow up visit will include the Patient Global Impression of Improvement (PGI-I) and an additional survey. The 12 month follow up visit will include a the PGI-I, PFDI-20 and an additional survey. All participants will also be assessed for any suture-related complications, such as erosion or granulation tissue. Follow up exams will be completed by one of two urogynecology nurse practitioners who will be blinded to the surgery and suture choice. Both nurse practitioners have extensive experience in performing POP-Q exams. The examiners will complete a follow up data abstraction form for each follow up appointment (6 weeks and 12 months). The follow up clinic appointments at 6 weeks and 12 months are the times of usually scheduled post-operative follow up for USLS procedures. Additionally, completion of the PFDI-20 questionnaire and a POP-Q exam constitute routine clinical care for these patients. As such, there is no additional time commitment for subjects compared to routine clinical care.

Interventions

DEVICEAbsorbent suture (polydioxanone) and Permanent suture (Gore-Tex CV2)

Sponsors

International Urogynecological Association
CollaboratorOTHER
Joseph Kowalski
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for uterosacral ligament suspension (USLS)

Exclusion criteria

* Non-English speaking * Prisoner * Cognitive impairment precluding informed consent * Planned hysteropexy

Design outcomes

Primary

MeasureTime frameDescription
Pelvic Organ Prolapse Quantification Exam (POP-Q) Point C12 monthsNon-inferiority of POP-Q point C. This measure was obtained as originally described by Bump et al. The hymen is used as a fixed reference point. In other words, this is point zero. Point C is measured in cm relative to the hymen with negative values being proximal to the hymen and positive values distal to the hymen. Point C represents either the most distal edge of the cervix or the leading edge of the vaginal cuff after total hysterectomy.

Secondary

MeasureTime frameDescription
Suture-related Complications6 weeks and 12 monthsThe presence of apical granulation tissue, apical suture exposure, abnormal vaginal discharge, vaginal spotting, post-coital spotting, dyspareunia or patient being able to feel suture.
Symptomatic Prolapse Outcomes12 monthsPositive response to PFDI-20 question #3 regarding the presence of a vaginal bulge (yes) AND the presence of bother (somewhat, moderately or quite a bit).

Countries

United States

Participant flow

Participants by arm

ArmCount
Absorbable
Absorbable suture (polydioxanone) for uterosacral ligament suspension (USLS) Absorbent suture (polydioxanone) and Permanent suture (Gore-Tex CV2)
22
Permanent
Permanent suture (Gore-Tex CV2) for uterosacral ligament suspension (USLS) Absorbent suture (polydioxanone) and Permanent suture (Gore-Tex CV2)
22
Total44

Baseline characteristics

CharacteristicPermanentTotalAbsorbable
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
11 Participants20 Participants9 Participants
Age, Categorical
Between 18 and 65 years
11 Participants24 Participants13 Participants
Age, Continuous63.6 years
STANDARD_DEVIATION 10.2
62.9 years
STANDARD_DEVIATION 12
62.1 years
STANDARD_DEVIATION 13.7
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
22 participants44 participants22 participants
Sex: Female, Male
Female
22 Participants44 Participants22 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 22
other
Total, other adverse events
2 / 224 / 22
serious
Total, serious adverse events
0 / 220 / 22

Outcome results

Primary

Pelvic Organ Prolapse Quantification Exam (POP-Q) Point C

Non-inferiority of POP-Q point C. This measure was obtained as originally described by Bump et al. The hymen is used as a fixed reference point. In other words, this is point zero. Point C is measured in cm relative to the hymen with negative values being proximal to the hymen and positive values distal to the hymen. Point C represents either the most distal edge of the cervix or the leading edge of the vaginal cuff after total hysterectomy.

Time frame: 12 months

ArmMeasureValue (MEDIAN)
AbsorbablePelvic Organ Prolapse Quantification Exam (POP-Q) Point C-7.25 cm
PermanentPelvic Organ Prolapse Quantification Exam (POP-Q) Point C-7 cm
Secondary

Suture-related Complications

The presence of apical granulation tissue, apical suture exposure, abnormal vaginal discharge, vaginal spotting, post-coital spotting, dyspareunia or patient being able to feel suture.

Time frame: 6 weeks and 12 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AbsorbableSuture-related Complications6 weeks17 Participants
AbsorbableSuture-related Complications12 months2 Participants
PermanentSuture-related Complications6 weeks14 Participants
PermanentSuture-related Complications12 months4 Participants
Secondary

Symptomatic Prolapse Outcomes

Positive response to PFDI-20 question #3 regarding the presence of a vaginal bulge (yes) AND the presence of bother (somewhat, moderately or quite a bit).

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AbsorbableSymptomatic Prolapse Outcomes1 Participants
PermanentSymptomatic Prolapse Outcomes4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026